View More View Less
  • 1 Mashhad University of Medical Sciences School of Pharmacy and Biotechnology Research Center Mashhad Iran
  • | 2 Mashhad University of Medical Sciences School of Medicine and Microbiology Research Center Mashhad Iran
  • | 3 Mashhad University of Medical Sciences School of Pharmacy Mashhad Iran
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Cross Mark

This study was conducted at a 900+ bed general teaching hospital, from May to September 2007, in Iran. The aim of this study was to determine the prevalence of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae and their antimicrobial pattern. The Kirby-Bauer disk diffusion method and the phenotypic disk confirmatory test were performed for each isolate. The total of 206 isolates including 106 E. coli and 100 K. pneumoniae were collected of which 122 isolates (59.2%) were ESBL positive. The prevalence of ESBL-producing strains was 59.2% (122/206). All the isolates were susceptible to imipenem. Among the ESBL-producing isolates, the sensitivity was from 3.3% to 61.5% for ampicillin to aztreonam. From female isolates (136), 59.5% and from male isolates (70), 58.6% were ESBL-producers. Ratios of isolates from hospitalized patients to out-patients were 94/28 in the ESBL-producing group. The number of ESBL-producing isolates according to the isolation sites showed a significant difference between ESBL-producers and non-producers in blood samples ( P <0.05). This study shows that the prevalence of ESBL strains in Iran is high. It seems necessary for clinicians and medical community personnel to be fully aware of ESBL-producing microorganisms.

  • Vakulenko, S. B., Geryk, B., Kotra, L. P., Mobashery, Sh., Lerner, S. A.: Selection and characterization of beta-lactam-beta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase gene. Antimicrob Agents Chemother 42 (7), 1542–1548 (1998).

    Lerner S. A. , 'Selection and characterization of beta-lactam-beta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase gene ' (1998 ) 42 Antimicrob Agents Chemother : 1542 -1548.

    • Search Google Scholar
  • Al-Jasser, A. M.: Extended spectrum beta-lactamases (ESBLs): a global problem. Kuwait Med J 38 , 171–185 (2006).

    Al-Jasser A. M. , 'Extended spectrum beta-lactamases (ESBLs): a global problem ' (2006 ) 38 Kuwait Med J : 171 -185.

    • Search Google Scholar
  • Paterson, D. L., Bonomo, R. A.: Extended spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18 , 657–686 (2005).

    Bonomo R. A. , 'Extended spectrum beta-lactamases: a clinical update ' (2005 ) 18 Clin Microbiol Rev : 657 -686.

    • Search Google Scholar
  • Shah, A. A., Hasan, F., Ahmed, S., Hameed, A.: Characteristics, epidemiology and clinical importance of emerging strains of gram-negative bacilli producing extended-spectrum beta-lactamases. Res Microbiol 155 , 409–421 (2004).

    Hameed A. , 'Characteristics, epidemiology and clinical importance of emerging strains of gram-negative bacilli producing extended-spectrum beta-lactamases ' (2004 ) 155 Res Microbiol : 409 -421.

    • Search Google Scholar
  • Rodriguez-Bano, J., Paterson, D. L.: A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms. Clin Infect Dis 42 , 935–937 (2006).

    Paterson D. L. , 'A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms ' (2006 ) 42 Clin Infect Dis : 935 -937.

    • Search Google Scholar
  • Podschun, R., Uilmann, U.: Klebsiella species as nosocomial pathogens: epidemiology, taxonomy, typing methods and pathogenicity factors. Clin Microbiol Rev 11 , 589–603 (1998).

    Uilmann U. , 'Klebsiella species as nosocomial pathogens: epidemiology, taxonomy, typing methods and pathogenicity factors ' (1998 ) 11 Clin Microbiol Rev : 589 -603.

    • Search Google Scholar
  • Chaudhary, U., Aggarwal, R.: Extended spectrum beta-lactamases: an emerging threat to clinical therapeutics. Indian J Med Microbiol 22 (2), 75–80 (2004).

    Aggarwal R. , 'Extended spectrum beta-lactamases: an emerging threat to clinical therapeutics ' (2004 ) 22 Indian J Med Microbiol : 75 -80.

    • Search Google Scholar
  • Reddy, P., Malczynski, M., Obias, A., Reiner, S., Jin, N., Huang, J., Noskin, G. A., Zembower, T.: Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis 45 , 846–852 (2007).

    Zembower T. , 'Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia ' (2007 ) 45 Clin Infect Dis : 846 -852.

    • Search Google Scholar
  • Rossolini, G. M., D’Andrea, M. M., Mugnaioli, C.: The spread of CTX-M-type extended-spectrum beta-lactamases. Clin Microbiol Infect 14 , 33–41 (2008).

    Mugnaioli C. , 'The spread of CTX-M-type extended-spectrum beta-lactamases ' (2008 ) 14 Clin Microbiol Infect : 33 -41.

    • Search Google Scholar
  • Piroth, L., Aubé, H., Doise, J. M., Vincent-Martin, M.: Spread of extended-spectrum betalactamase-producing Klebsiella pneumoniae: Are beta-lactamase inhibitors of therapeutic value? Clin Infect Dis 27 , 76–80 (1998).

    Vincent-Martin M. , 'Spread of extended-spectrum betalactamase-producing Klebsiella pneumoniae: Are beta-lactamase inhibitors of therapeutic value? ' (1998 ) 27 Clin Infect Dis : 76 -80.

    • Search Google Scholar
  • Shivaprakasha, Sh., Radhakrishnan, K., Gireesh, A. R., Shamsul Karim, S. M.: Routine screening for ESBL production, a necessity of today. Int J Microbio 3 (2007).

  • Feizabadi, M. M., Etemadi, G., Yadegarinia, D., Rahmati M., Shabanpoor, Sh., Bokaei, S.: Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pnemoniae in Tehran. Med Sci Monit 12 , 362–365 (2006).

    Bokaei S. , 'Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pnemoniae in Tehran ' (2006 ) 12 Med Sci Monit : 362 -365.

    • Search Google Scholar
  • Masjedian, F., Valehi, F., Talebi, A. A., Rastegar, Lari: Evaluation of wide broad spectrum antibiotic resistance of Escherichia coli and Klebsiella pneumoniae . IJMM 1 (2), 27–34 (2007).

    Rastegar L. , 'Evaluation of wide broad spectrum antibiotic resistance of Escherichia coli and Klebsiella pneumoniae ' (2007 ) 1 IJMM : 27 -34.

    • Search Google Scholar
  • Mackie and Mc Cartney. In: Practical Medical Microbiology. Collee, J. G., Fraser, A. G., Marmion, B. P., Simmons, A. (eds). 14 th ed. London (UK): Churchill Livingstone, pp. 361–413 (1996).

    Mc Cartney , '', in Practical Medical Microbiology , (1996 ) -.

  • Bauer, A. W., Kirby, W. M. M., Sherris, J. C., Jurek, M.: Antibiotic susceptibility testing by a standardized single method. Am J Clin Pathol 45 , 493–496 (1996).

    Jurek M. , 'Antibiotic susceptibility testing by a standardized single method ' (1996 ) 45 Am J Clin Pathol : 493 -496.

    • Search Google Scholar
  • Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7 th ed. Approved standard M7-A7. CLSI, Wayne, PA (2006).

    '', in (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , (2006 ) -.

  • Goossens, H.: MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from Europe: Comparison of antibiotic susceptibility between countries and center types. J Antimicrob Chemother 46 (Suppl T2), 39–52 (2000).

    Goossens H. , 'MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from Europe: Comparison of antibiotic susceptibility between countries and center types ' (2000 ) 46 J Antimicrob Chemother : 39 -52.

    • Search Google Scholar
  • Andrews, J. M.: BSAC Working Party On Susceptibility Testing ft. BSAC standardized susceptibility testing method. J Antimicrob Chemother 48 (Suppl S1), 43–57 (2001).

    Andrews J. M. , 'BSAC Working Party On Susceptibility Testing ft. BSAC standardized susceptibility testing method ' (2001 ) 48 J Antimicrob Chemother : 43 -57.

    • Search Google Scholar
  • El-Khizzi, N. A., Bakheshwain, S. M.: Prevalence of extended spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital. Saudi Med J 27 (1), 37–40 (2006).

    Bakheshwain S. M. , 'Prevalence of extended spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital ' (2006 ) 27 Saudi Med J : 37 -40.

    • Search Google Scholar
  • Meyer, K. S., Urban, C., Eagan, J. A., Berger, B. J., Rahal, J. J.: Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 119 (5), 353–358 (1993).

    Rahal J. J. , 'Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins ' (1993 ) 119 Ann Intern Med : 353 -358.

    • Search Google Scholar
  • Karas, J. A., Pillay, D. G., Muckart, D., Sturm, A. W.: Treatment failure due to extendedspectrum beta-lactamase. J Antimicrob Chemother 37 (1), 203–204 (1996).

    Sturm A. W. , 'Treatment failure due to extendedspectrum beta-lactamase ' (1996 ) 37 J Antimicrob Chemother : 203 -204.

    • Search Google Scholar
  • Pagani, L., Migliavacca, R., Pallecchi, L., Matti, C., Giacobone, E., Amicosante, G., Romero, E., Mossolini, R. G.: Emerging extended-spectrum beta-lactamases in Proteus mirabilis . J Clin Microbiol 40 (4), 1549–1552 (2002).

    Mossolini R. G. , 'Emerging extended-spectrum beta-lactamases in Proteus mirabilis ' (2002 ) 40 J Clin Microbiol : 1549 -1552.

    • Search Google Scholar
  • Jacoby, G. A., Han, P.: Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli . J Clin Microbiol 34 , 908–911 (1996).

    Han P. , 'Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli ' (1996 ) 34 J Clin Microbiol : 908 -911.

    • Search Google Scholar
  • Bradford, P. A.: Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14 , 933–951 (2001).

    Bradford P. A. , 'Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat ' (2001 ) 14 Clin Microbiol Rev : 933 -951.

    • Search Google Scholar
  • Stobberingh, E. E., Arends, J., Hoogkamp-Korstanje, J. A. A., Goessens, W. H. F., Visser, M. R., Buiting, A. G., Debets-Ossenkopp, Y. J., Ketel, R. J. van, Ogtrop, M. L. van, Sabbe, L. J., Voorn, G. P., Winter, H. L. J., Zeijl, J. H. van.: Occurrence of extended-spectrum betalactamases (ESBL) in Dutch Hospitals. Infection 27 (6), 348–354 (1999).

    Zeijl J. H. , 'Occurrence of extended-spectrum betalactamases (ESBL) in Dutch Hospitals ' (1999 ) 27 Infection : 348 -354.

    • Search Google Scholar
  • Bell, J. M., Turnidge, J. D., Gales Pfaller, A. C. M. A., Jones, R. N.: Prevalence of extendedspectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998–99). Diagn Microbiol Infect Dis 42 , 193–198 (2002).

    Jones R. N. , 'Prevalence of extendedspectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998–99) ' (2002 ) 42 Diagn Microbiol Infect Dis : 193 -198.

    • Search Google Scholar
  • Hernández, J. R., Martínez-Martínez, L., Cantón, R., Coque, T. M., Pascual, A. and Spanish Group for Nosocomial Infections (GEIH): Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrob Agents Chemother 49 (5), 2122–2125 (2005).

    Pascual A. , 'Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain ' (2005 ) 49 Antimicrob Agents Chemother : 2122 -2125.

    • Search Google Scholar
  • Ozgunes, I., Erben, N., Kiremitci, A., Kartal, E., Durmaz, G., Colak, H., Usluer, G., Colak, E.: The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors. Saudi Med J 27 (5), 608–612 (2006).

    Colak E. , 'The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors ' (2006 ) 27 Saudi Med J : 608 -612.

    • Search Google Scholar
  • Navon-Venezia, Sh., Hammer-Munz, O., Schwartz, D., Turner, D., Kuzmenko, B., Carmeli, Y.: Occurrence and phenotypic characteristics of extended-spectrum beta-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests. J Clinic Microbiol 41 (1), 155–158 (2003).

    Carmeli Y. , 'Occurrence and phenotypic characteristics of extended-spectrum beta-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests ' (2003 ) 41 J Clinic Microbiol : 155 -158.

    • Search Google Scholar
  • Menon, T., Bindu, D., Kumar, C. P. G., Nalini, S., Thirunarayan, M. A.: Comparison of double disc and three dimensional methods to screen for ESBL-producers in a tertiary care hospital. Indian J Med Microbiol 24 (2), 117–120 (2006).

    Thirunarayan M. A. , 'Comparison of double disc and three dimensional methods to screen for ESBL-producers in a tertiary care hospital ' (2006 ) 24 Indian J Med Microbiol : 117 -120.

    • Search Google Scholar
  • Khurana, S. N. M.: Extended-spectrum beta-lactamase mediated resistance in urinary tract isolates of family Enterobacteriaceae. Indian J Med Res 116 , 145–149 (2002).

    Khurana S. N. M. , 'Extended-spectrum beta-lactamase mediated resistance in urinary tract isolates of family Enterobacteriaceae ' (2002 ) 116 Indian J Med Res : 145 -149.

    • Search Google Scholar
  • Kumar, M. S., Lakshim, V., Rajagopalan, R.: Occurrence of extended spectrum beta-lactamases among Enterobacteriaceae spp. Isolated at a tertiary care institute. Indian J Med Microbiol 24 (3), 208–211 (2006).

    Rajagopalan R. , 'Occurrence of extended spectrum beta-lactamases among Enterobacteriaceae spp. Isolated at a tertiary care institute ' (2006 ) 24 Indian J Med Microbiol : 208 -211.

    • Search Google Scholar
  • Kjerulf, A., Hansen, D. S., Sandvangm, D., Hansen, F., Frimodt-Møller, N.: The prevalence of ESBL-producing Escherichia coli and Klebsiella strains in the Copenhagen area of Denmark. APMIS Fe b 116 (2), 118–124 18321362 (P,S,E,B,D) (2008).

    Frimodt-Møller N. , 'The prevalence of ESBL-producing Escherichia coli and Klebsiella strains in the Copenhagen area of Denmark ' (2008 ) 116 APMIS Feb : 118 -124.

    • Search Google Scholar
  • Babay, H. A.: Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a teaching hospital, Riyadh, Kingdom of Saudi Arabia. Saudi Med J 23 , 186–190 (2002).

    Babay H. A. , 'Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a teaching hospital, Riyadh, Kingdom of Saudi Arabia ' (2002 ) 23 Saudi Med J : 186 -190.

    • Search Google Scholar
  • Coudron, P. E., Moland, E. S., Sanders, C. C.: Occurrence and detection of extended-spectrum beta-lactamase in members of Enterobacteriaceae of veterans Medical Center: Seek and You May Find. J Clin Microbiol 35 , 2593–2597 (1997).

    Sanders C. C. , 'Occurrence and detection of extended-spectrum beta-lactamase in members of Enterobacteriaceae of veterans Medical Center: Seek and You May Find ' (1997 ) 35 J Clin Microbiol : 2593 -2597.

    • Search Google Scholar
  • Bantar, C., Famiglietti, A., Goldberg, M.: Three-year surveillance study of nosocomial bacterial resistance in Argentina. The Antimicrobial Committee; and the National Surveillance Program (SIR) Participants Group. Int J Infect Dis 4 , 85–90 (2000).

    Goldberg M. , 'Three-year surveillance study of nosocomial bacterial resistance in Argentina. The Antimicrobial Committee; and the National Surveillance Program (SIR) Participants Group ' (2000 ) 4 Int J Infect Dis : 85 -90.

    • Search Google Scholar
  • Selvakumar, B. N., Jasmin, R.: Antibiotic susceptibility of ESBL-producing urinary isolates at a tertiary care hospital in Tiruchirappalli, South India. J Med Sci 7 (3), 443–446 (2007).

    Jasmin R. , 'Antibiotic susceptibility of ESBL-producing urinary isolates at a tertiary care hospital in Tiruchirappalli, South India ' (2007 ) 7 J Med Sci : 443 -446.

    • Search Google Scholar
  • Mehrgan, H., Rahbar, M.: Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Int J Antimicrob Agents 31 (2), 147–151 (2008).

    Rahbar M. , 'Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran ' (2008 ) 31 Int J Antimicrob Agents : 147 -151.

    • Search Google Scholar
  • Subha, A., Ananthan, S.: Extended spectrum beta-lactamase (ESBL) mediated resistance to third generation cephalosporins among Klebsiella pneumoniae in Chennai. Indian J Med Microbiol 20 (2), 92–95 (2002).

    Ananthan S. , 'Extended spectrum beta-lactamase (ESBL) mediated resistance to third generation cephalosporins among Klebsiella pneumoniae in Chennai ' (2002 ) 20 Indian J Med Microbiol : 92 -95.

    • Search Google Scholar
  • Mushtaq, S., Hope, R., Warner, M., Livermore, D. M.: Activity of faropenem against cephalosporin-resistant Enterobacteriaceae. J Antimicrob Chemother 59 (5), 1025–1030 (2007).

    Livermore D. M. , 'Activity of faropenem against cephalosporin-resistant Enterobacteriaceae ' (2007 ) 59 J Antimicrob Chemother : 1025 -1030.

    • Search Google Scholar
  • Kizirgil, A., Demirdag, K., Mehmet, O., Bulut, Y., Yakupogullari, Y., Toraman, Z. A.: In vitro activity of three different antimicrobial agents ESBL-producing Escherichia coli and Klebsiella pneumoniae blood isolates. Microbiol Res 160 , 135–140 (2005).

    Toraman Z. A. , 'In vitro activity of three different antimicrobial agents ESBL-producing Escherichia coli and Klebsiella pneumoniae blood isolates ' (2005 ) 160 Microbiol Res : 135 -140.

    • Search Google Scholar
  • Rice, L.: Evaluation and clinical importance of extended-spectrum beta-lactamase. Chest 119 (2), 391–369 (2001).

    Rice L. , 'Evaluation and clinical importance of extended-spectrum beta-lactamase ' (2001 ) 119 Chest : 391 -369.

    • Search Google Scholar
  • Lautenbach, E., Strom, B. L., Bilker, W. B., Patel, J. B., Edelstein, P. H., Fishman, N. O.: Epidemiological investigation of fluoroquinolone resistance in infections due to ESBL-producing Escherichia coli and K.penumoniae . Clin Infect Dis 33 , 1288–1294 (2001).

    Fishman N. O. , 'Epidemiological investigation of fluoroquinolone resistance in infections due to ESBL-producing Escherichia coli and K.penumoniae ' (2001 ) 33 Clin Infect Dis : 1288 -1294.

    • Search Google Scholar
  • Paterson, D. L., Mulazimoglu, L., Casellas, J. M., Ko, W. C., Goossens, H., GoHberg, A. von, Mohapatra, S., Trenholme, G. M., Klugman, K. P., McCormark, J. C., Yu, V. L.: Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum betalactamase production in Klebsiella pneumoniae isolates causing bactermia. Clin Infec Dis 30 , 473–478 (2000).

    Yu V. L. , 'Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum betalactamase production in Klebsiella pneumoniae isolates causing bactermia ' (2000 ) 30 Clin Infec Dis : 473 -478.

    • Search Google Scholar
  • Goyanes, M. J., Cercenado, E., Insa, R., Morente, A., Alcala, L.: Enterobacteriaceae: Comparative analysis between clinical isolates resistant and susceptible to third generation cephalosporins. Rev ESP Quimioterap 20 (2), 216–221 (2007).

    Alcala L. , 'Enterobacteriaceae: Comparative analysis between clinical isolates resistant and susceptible to third generation cephalosporins ' (2007 ) 20 Rev ESP Quimioterap : 216 -221.

    • Search Google Scholar
All Time Past Year Past 30 Days
Abstract Views 61 61 0
Full Text Views 7 5 0
PDF Downloads 4 4 0